Home > About Spectrum
Accelerating research to improve health for all
Spectrum is the Stanford Center for Clinical and Translational Research and Education—bridging each stage of medical innovation from basic research to public health.
A CTSA Hub
Spectrum—the Stanford Center for Clinical and Translational Research and Education—is home to the Stanford Clinical & Translational Science Award (CTSA), funded by the NIH National Center for Advancing Translational Sciences (NCATS). NCATS was established in 2012 to transform the translational science process so that new treatments and cures for disease can be delivered to patients faster. Stanford joins a national network of 50-plus research “hubs” that collaborate to share innovations in training, research tools, and processes.
Our Mission
Since its inception in 2006, Spectrum’s mission has been to transform clinical and translational research and education at Stanford and across the CTSA consortium. Our goal is to make our CTSA more effective and efficient at discovering and implementing data- and metrics-driven strategies to serve the health needs of individuals and populations.
Spectrum’s programs in clinical and translational research and education have been designed to extend from the earliest stages of the translational pipeline to the “final mile” of implementation science at patient and population levels, and to take full advantage of the rich set of research and educational resources available across Stanford University.
In the next five years, the goal is to further leverage local and regional progress in team science, institutional strengths and resources, and multiple advancements to better implement the objectives of the overall CTSA program. In so doing, the Spectrum CTSA can nurture an innovative and collaborative workforce focused on identifying, optimizing, evaluating, and then transferring relevant health discoveries to patients and the community.
The Overarching Aims of Our CTSA Grant (UL1TR003142)
Educate the next generation of investigators who make up the clinical and translational research (CTR) “workforce” with the skills to carry out innovative clinical, translational, and implementation research to meet the opportunities and challenges of healthcare delivery and wellness maintenance in the 21st Century.
By the numbers
Spectrum’s COVID-19 Work
~7,400
Registrants
in the Spectrum-supported Research Registry with a COVID-19 focus, launched in April 2020.
284
COVID-19-positive registrants
invited to join the “COVID Long Haul” study/survey, documenting persistent symptoms and experiences.
90
Study/survey participants
who will be asked to complete a similar survey every three months to document if/how their symptoms persist.
Additional Resources
Spectrum External Advisory Board
Our external advisory board supports leadership with insightful strategic direction.